Cargando…
Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement
BACKGROUND: The advantage of up‐front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications. METHODS: The data of 41 and 14 patients with stage IVA/B (T1–T3 and ≥N2a) HPC...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292839/ https://www.ncbi.nlm.nih.gov/pubmed/34549854 http://dx.doi.org/10.1002/hed.26881 |
_version_ | 1784749472492814336 |
---|---|
author | Sato, Mitsuo P. Otsuki, Naoki Kitano, Mutsukazu Ishikawa, Kazuki Tanaka, Kaoru Kimura, Takayuki Doi, Katsumi |
author_facet | Sato, Mitsuo P. Otsuki, Naoki Kitano, Mutsukazu Ishikawa, Kazuki Tanaka, Kaoru Kimura, Takayuki Doi, Katsumi |
author_sort | Sato, Mitsuo P. |
collection | PubMed |
description | BACKGROUND: The advantage of up‐front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications. METHODS: The data of 41 and 14 patients with stage IVA/B (T1–T3 and ≥N2a) HPC who underwent UFND followed by CRT and received CRT, respectively, were retrospectively analyzed and compared. RESULTS: The 5‐year overall survival (OS) and disease‐specific survival rates for the UFND and CRT groups were 61% and 52% (p = 0.1019), and 89% and 74% (p = 0.2333), respectively. Moreover, patients aged ≥70 years or those with a pulmonary disease history had a significantly poorer prognosis due to aspiration pneumonia in the UFND group. The 5‐year regional control (RC) for the UFND and CRT groups were 92% and 57%, respectively (p = 0.0001). CONCLUSIONS: UFND followed by CRT was feasible with satisfactory RC. To further improve OS, aspiration pneumonia prevention is essential. |
format | Online Article Text |
id | pubmed-9292839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92928392022-07-20 Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement Sato, Mitsuo P. Otsuki, Naoki Kitano, Mutsukazu Ishikawa, Kazuki Tanaka, Kaoru Kimura, Takayuki Doi, Katsumi Head Neck Original Articles BACKGROUND: The advantage of up‐front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications. METHODS: The data of 41 and 14 patients with stage IVA/B (T1–T3 and ≥N2a) HPC who underwent UFND followed by CRT and received CRT, respectively, were retrospectively analyzed and compared. RESULTS: The 5‐year overall survival (OS) and disease‐specific survival rates for the UFND and CRT groups were 61% and 52% (p = 0.1019), and 89% and 74% (p = 0.2333), respectively. Moreover, patients aged ≥70 years or those with a pulmonary disease history had a significantly poorer prognosis due to aspiration pneumonia in the UFND group. The 5‐year regional control (RC) for the UFND and CRT groups were 92% and 57%, respectively (p = 0.0001). CONCLUSIONS: UFND followed by CRT was feasible with satisfactory RC. To further improve OS, aspiration pneumonia prevention is essential. John Wiley & Sons, Inc. 2021-09-22 2021-12 /pmc/articles/PMC9292839/ /pubmed/34549854 http://dx.doi.org/10.1002/hed.26881 Text en © 2021 The Authors. Head & Neck published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Sato, Mitsuo P. Otsuki, Naoki Kitano, Mutsukazu Ishikawa, Kazuki Tanaka, Kaoru Kimura, Takayuki Doi, Katsumi Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement |
title | Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement |
title_full | Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement |
title_fullStr | Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement |
title_full_unstemmed | Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement |
title_short | Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement |
title_sort | up‐front neck dissection followed by chemoradiotherapy for t1–t3 hypopharyngeal cancer with advanced nodal involvement |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292839/ https://www.ncbi.nlm.nih.gov/pubmed/34549854 http://dx.doi.org/10.1002/hed.26881 |
work_keys_str_mv | AT satomitsuop upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement AT otsukinaoki upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement AT kitanomutsukazu upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement AT ishikawakazuki upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement AT tanakakaoru upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement AT kimuratakayuki upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement AT doikatsumi upfrontneckdissectionfollowedbychemoradiotherapyfort1t3hypopharyngealcancerwithadvancednodalinvolvement |